Bio-Bridge Science (BGES.OB) Listed On OTC BB
21 October 2005 - 2:00AM
Business Wire
Bio-Bridge Science, an Oak Brook Illinois-based biotech company,
announced today that its shares are now listed on the
Over-the-Counter Bulletin Board under the ticker symbol "BGES". "We
are very pleased to see our stock listed on the electronic bulletin
board", said Chairman and CEO Liang Qiao. "Our company is engaged
in cutting-edge research in a vitally important field of medicine.
Our unique technology and our presence on the ground in China,
where AIDS infection rates are spiraling upwards, puts us at the
forefront of the fight against the global AIDS pandemic. Our
listing on a U.S. exchange will enable us to more effectively
communicate our progress to investors." Bio-Bridge Science is a
biotechnology firm focused on the development of vaccines with
broad therapeutic and preventive applications. Through its wholly
owned subsidiary in Beijing, Bio-Bridge is developing a promising
new HIV Vaccine, that is expected to enter clinical trials early
next year in China. The vaccine, based on exclusive technology
co-developed by CEO Liang Qiao, an associate professor at Loyola
University Chicago's Strich School of Medicine, targets infection
in mucosal tissues, the first type of tissue attacked by HIV. The
Chinese government, mindful of the rapid expansion of AIDS in China
has, through the "Green Mile Policy" acted to expedite the approval
of domestically produced HIV Vaccines and has dramatically
increased its spending on AIDS-related research. In accordance with
this policy, Bio-Bridge expects to bring its therapeutic HIV
Vaccine to market as early as 2008, far in advance of many other
HIV Vaccines currently in development. Bio-Bridge is currently
constructing a new $3 million state-of-the-art GMP research and
manufacturing facility in Beijing, which is expected to be
completed by the end of this year.
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bio Bridge Science Inc (CE) (OTCMarkets): 0 recent articles
More Bio-Bridge Science News Articles